If concomitant use with other serotonergic medicine or CYP2D6 inhibitors is clinically warranted, initiate therapy with reduced doses, monitor individuals with the emergence of serotonin syndrome through drug initiation or titration, and inform clients of improved hazard for serotonin syndrome Appropriate reports haven't been executed on the con